0001127602-17-017792.txt : 20170511
0001127602-17-017792.hdr.sgml : 20170511
20170511181415
ACCESSION NUMBER: 0001127602-17-017792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170509
FILED AS OF DATE: 20170511
DATE AS OF CHANGE: 20170511
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GILEAD SCIENCES INC
CENTRAL INDEX KEY: 0000882095
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943047598
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
BUSINESS PHONE: 6505743000
MAIL ADDRESS:
STREET 1: 333 LAKESIDE DR
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cogan John Francis
CENTRAL INDEX KEY: 0001319872
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19731
FILM NUMBER: 17835725
MAIL ADDRESS:
STREET 1: 2010 NORTH FIRST STREET, SUITE 310
CITY: SAN JOSE
STATE: CA
ZIP: 95131
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2017-05-09
0000882095
GILEAD SCIENCES INC
GILD
0001319872
Cogan John Francis
333 LAKESIDE DRIVE
FOSTER CITY
CA
94404
1
Common Stock
2017-05-09
4
M
0
1787
A
47562
D
Common Stock
2017-05-09
4
M
0
15000
20.705
A
62562
D
Common Stock
2017-05-09
4
S
0
9943
67.25
D
52619
D
Restricted Stock Unit
2017-05-09
4
M
0
1787
D
Common Stock
1787
0
D
Non-qualified Stock Option (Right to Buy)
20.705
2017-05-09
4
M
0
15000
0
D
2017-05-09
Common Stock
15000
0
D
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
100% of the restricted stock units vested on May 9, 2017.
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
Options are 100% vested on the date of grant.
/s/ Marissa Song by Power of Attorney for John F. Cogan
2017-05-11
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POA
Power of Attorney
Know all by these presents, that the undersigned hereby
constitutes and appoints each of Robin L. Washington, Gregg H. Alton,
Paul Carter, Brett A. Pletcher, Katie Watson, Jason Okazaki, Diane Wilfong
and Marissa Song, signing individually, the undersigned?s true and lawful
attorneys-in-fact and agents to:
(1) execute for and on behalf of the undersigned, an officer or
director of Gilead Sciences, Inc. (the ?Company?), Forms 3, 4 and
5 in accordance with Section 16(a) of the Securities Exchange Act of
1934, as amended (the ?Exchange Act?) and the rules there under;
(2) do and perform any and all acts for and on behalf of the undersigned
that may be necessary or desirable to complete and execute such Form 3, 4
or 5, complete and execute and amendment or amendments thereto, and timely
file such forms or amendments with United States Securities and Exchange
Commission and any stock exchange or similar authority; and
(3)take any other action of any nature whatsoever in connection with the
foregoing which, in the opinion of such attorney-in-fact, may be of
benefit, in the best interest of, or legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such terms
and conditions as such attorney-in-fact may approve in such
attorney-in-fact?s discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing
whatsoever requisite, necessary, or proper to be done in the exercise of
any of the rights and powers herein granted, fully to all intents and
purpose as the undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact?s substitute or
substitutes, shall lawfully do or cause to be done by virtue of this power
of attorney and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such
capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned?s responsibilities to comply
with Section 16 of the Exchange Act.
This Power of Attorney shall remain in full force and effect
until the earliest to occur of (a) the undersigned is no longer required
to file Forms 3, 4 and 5 with respect to the undersigned?s holdings of
and transactions in securities issued by the Company, (b) revocation by
the undersigned in a signed writing delivered to the foregoing
attorney?s-in-fact or (c) as to any attorney-in-fact individually, until
such attorney-in-fact shall no longer be employed by the Company.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 11th day of May 2016.
/s/John F. Cogan